MedPath
NMPA Approval

Olopatadine Hydrochloride Eye Drops

国药准字H20254150

May 13, 2025

Drug Information

盐酸奥洛他定滴眼液

眼用制剂

0.1%(5ml:5mg,按C₂₁H₂₃NO₃计)

化学药品

May 13, 2025

Company Information

Applicant Company

石家庄高新区秦岭大街588号

Manufacturing Company

石家庄高新区秦岭大街588号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸奥洛他定滴眼液 - NMPA 批准文号 | MedPath